Long-term lymphocytic leukemia (CLL) is actually a lymphoid malignancy characterised by the proliferation and accumulation of experienced CD5+ B cells from the blood, bone marrow and lymphoid tissues. The prognosis of CLL calls for the presence of ?5 x109/L mono - clonal B cells of typical phenotype in the blood.Cure for relapsed/refractory disease